Provided by Tiger Trade Technology Pte. Ltd.

Balchem

177.50
-3.7800-2.09%
Pre-market: 177.01-0.4900-0.28%08:39 EDT
Volume:279.52K
Turnover:49.99M
Market Cap:5.68B
PE:34.94
High:182.99
Open:181.62
Low:177.38
Close:181.28
52wk High:183.90
52wk Low:139.17
Shares:32.03M
Float Shares:31.65M
Volume Ratio:2.03
T/O Rate:0.88%
Dividend:0.96
Dividend Rate:0.54%
EPS(TTM):5.08
EPS(LYR):4.75
ROE:12.79%
ROA:8.24%
PB:4.36
PE(LYR):37.37

Loading ...

Balchem-backed trial links vitamin K2 MK-7 to improved neuromuscular signaling in seniors

Reuters
·
Apr 21

Balchem says Thailand FDA approves OptiMSM ingredient

Reuters
·
Apr 16

Balchem study shows VitaCholine boosts working memory network connectivity in postmenopausal women

Reuters
·
Apr 16

Balchem schedules quarterly call to discuss first-quarter results

Reuters
·
Apr 16

Balchem files Form 3 for Chief Accounting Officer Erin Leigh Gilson

Reuters
·
Apr 08

Balchem clinical study flags K2VITAL post-exercise neuromuscular signaling potential in older adults

Reuters
·
Apr 02

Assessing Balchem (BCPC) Valuation After Recent Share Price Gains And Multi Year Returns

Simply Wall St.
·
Mar 31

Balchem Currently Down 10 Consecutive Days, on Track for Longest Losing Streak Since October 2018 -- Data Talk

Dow Jones
·
Mar 19

Balchem Launches Metalosate® T.E.A.M.™ Plant Tissue Analysis Digital Platform to Deliver Research-Driven Nutrient Recommendations for Specialty Crops

GlobeNewswire
·
Mar 09

Balchem to Participate in BNP Paribas Exane Consumer Ingredients & Chemicals Conference

Reuters
·
Feb 25

Balchem to Participate in JP Morgan Consumer Ingredients Forum

Reuters
·
Feb 24

Balchem Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 24

Balchem: Robust Growth Outlook, Margin Resilience, and Structural Tailwinds Support Buy Rating and $190 Target

TIPRANKS
·
Feb 24

Balchem Earnings Call Highlights Record Growth and Strength

TIPRANKS
·
Feb 21

Balchem Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 20

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Investors Digest Key Economic Data, Geopolitical Tensions

MT Newswires Live
·
Feb 20

BRIEF-Balchem Corporation Reports Fourth Quarter And Full Year 2025 Financial Results

Reuters
·
Feb 20

Balchem Q4 Sales USD 263.6 Million

Reuters
·
Feb 20

Balchem Q4 revenue beats on Human Nutrition and Health unit strength

Reuters
·
Feb 20

Balchem Q4 net earnings rise 16.8% to USD 39.2 million

Reuters
·
Feb 20